This was especially true for the BRCA1 classification, for which all sporadic basal-like tumors were misclassified as BRCA1. To avoid any potential confounding effects of the tumor subtypes, we wanted to test whether stratification by molecular subtypes could improve BRCA1/2 classifications. The gene discussed is BRCA1; the disease is neoplasm.